Voima Ventures, a Helsinki, Finland-based early-stage investor focusing on science-based companies across Nordic and Baltic countries, announced the first closing with a new €90m fund.
Investors in Fund III include among others European Investment Fund EIF, Finnish Tesi and its fund of funds KRR, VTT of Finland, Saminvest from Sweden, and pension funds Nordea Life and Elo, as well as established foundations, and family offices.
With the new fund, Voima Ventures’ mission is to support Nordic and Baltic early-stage deep tech companies with globally scalable solutions, with the initial investment ticket size ranging from €200K to €3 million and beyond.
Led by Inka Mero, Founding Partner, Voima Ventures invests in companies tackling pressing global challenges with science-driven entrepreneurship. The investment thesis focuses on the highest value-creating opportunities in the venture capital domain; solutions that accelerate global green transformation, life science and health technologies, and new technologies, such as quantum, that are changing entire industries.
Since its founding year 2019, the firm has had a strong track record in investing in high-potential science-based solutions by being an early investor in companies and next-generation unicorns like game-changing novel protein developer Solar Foods, AR pioneer Dispelix, carbon-neutral construction material company Betolar, and AI-based cancer treatment provider MVision.
The previous two funds have 30 active companies of which several have grown into globally scaling companies, including 5 exits and one IPO.
FinSMEs
13/06/2023